Tag: Gilead Sciences

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Gilead Sciences, Inc.’s recently made public that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.14 million

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Gilead Sciences, Inc.’s recent filing unveils that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.14 million